Geneva, June 22 -- International Clinical Trials Registry received information related to the study (NCT07645755) titled 'CRETA (Clopidogrel Responsiveness in Essential ThrombocithemiA)' on June 9.
Study Type: Observational
Primary Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Condition:
Essential Thrombocythemia
Intervention:
Diagnostic Test: VerifyNow P2Y12 assay
Recruitment Status: Not recruiting
Date of First Enrollment: July 15, 2026
Target Sample Size: 50
Countries of Recruitment:
Italy
To know more, visit https://clinicaltrials.gov/study/NCT07645755
Published by HT Digital Content Services with permission from Health Daily Digest....